查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869910

智慧注射器市場規模、佔有率和趨勢分析報告：按產品、分銷管道、應用、技術、地區和細分市場預測（2025-2033 年）

Smart Syringes Market Size, Share & Trends Analysis Report By Product (Auto-Disable Syringes, Passive Safety Syringes), By Distribution Channel, By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

智慧注射器市場摘要

2024年全球智慧注射器市場規模估計為10.5億美元，預計到2033年將達到22.2億美元。

預計從 2025 年到 2033 年，該行業將以 8.7% 的複合年成長率成長。這一成長是由人們對患者和醫護人員安全的日益關注所驅動的，特別是由於針刺傷 (NSI) 的增加以及 HIV 和肝炎等血液傳播疾病的傳播。

政府主導的疫苗宣傳活動和免疫舉措，特別是像印度全民免疫計劃（UIP）這樣的項目，正在推動對自動失效智慧注射器的需求。此外，美國和歐洲的監管機構正在強制要求使用安全設計的注射器，鼓勵醫療機構採用智慧注射器。智慧注射器融合了自動存儲和自動失效等安全設計功能，顯著降低了意外針刺傷的風險。這已成為一項重大的公共衛生挑戰，尤其對醫院和診所的醫護人員而言。例如，《國際外科全球健康雜誌》2024年的報告指出，針刺傷（NSI）主要發生在內科和外科，佔所有針刺傷事件的50%以上。

高風險區域包括創傷/急診室（38%）和手術室（3%）。在導致針刺傷的主要產品中，糖尿病患者的胰島素是罪魁禍首之一。醫護人員，包括急救人員、外科醫師和護士，尤其面臨風險。在全球範圍內，護理師的針刺傷發生率估計為42.8%，醫生為46.4%，護理專業學生為45.3%。雖然護理師的針刺傷發生率通常在41%左右，但護理專業學生的發生率差異很大，從8.7%到71%不等。

國際社會為提高免疫接種覆蓋率所做的努力，尤其是在發展中地區，顯著提升了對一次性智慧注射器的需求。這些注射器專為一次性使用而設計，有效防止重複使用，從而提高了疫苗安全性。在印度，全民免疫計畫（UIP）是規模最大的公共衛生計畫之一，每年涵蓋約2,670萬新生兒和2,900萬孕婦。 UIP被公認為最具成本效益的衛生干預措施之一，已顯著降低了五歲以下兒童因疫苗可預防疾病導致的死亡率。

愛滋病毒、B型肝炎病毒（HBV）和丙型肝炎病毒（HCV）等血液傳播疾病的日益增多是智慧注射器市場的主要驅動力。不安全的注射操作，包括重複使用注射器和針頭，是造成這些感染疾病傳播的重要因素，尤其是在開發中國家和醫療資源匱乏的地區。智慧注射器，包括自毀式和安全型設計，旨在防止重複使用和意外針刺傷，在降低感染風險方面發揮著至關重要的作用。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 智慧注射器市場變數、趨勢與範圍

  • 市場體系展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 智慧注射器市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章：智慧注射器市場：產品估算與趨勢分析

  • 細分儀表板
  • 智慧注射器市場：產品差異分析及市場佔有率（2024 年及 2033 年）
  • 自動禁用注射器
  • 被動安全注射器
  • 主動安全注射器

第5章：智慧注射器市場：應用預測與趨勢分析

  • 細分儀表板
  • 智慧注射器市場：應用變化分析及市場佔有率（2024 年及 2033 年）
  • 藥物輸送
    • 胰島素
    • 疫苗
    • 荷爾蒙療法
    • 腫瘤藥物
    • 其他
  • 血液檢體採集
  • 導管注射器沖洗
  • 其他特殊注射

第6章：智慧注射器市場：通路估算與趨勢分析

  • 細分儀表板
  • 智慧注射器市場：通路變化分析及市場佔有率（2024 年及 2033 年）
  • 直接競標（政府和非政府組織）
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第7章：智慧注射器市場：技術預測與趨勢分析

  • 細分儀表板
  • 智慧注射器市場：技術變革分析及市場佔有率（2024 年及 2033 年）
  • 伸縮式技術
  • 針頭保護裝置技術

第8章 智慧注射器市場：按產品、應用、分銷管道和技術分類的區域估算和趨勢分析

  • 區域展望
  • 智慧注射器市場：區域差異分析及市場佔有率（2024 年及 2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 市場參與企業分類
  • 主要企業簡介
    • Becton, Dickinson and Company（BD）
    • Hindustan Syringes &Medical Devices（HMD）
    • Terumo Corporation
    • Nipro Corporation
    • Retractable Technologies, Inc.
    • SCHOTT Pharma
    • Schreiner MediPharm
    • Gerresheimer AG
    • SPM Medicare
    • Restek Corporation
    • Shimadzu
    • Trajan LPP
    • Liaoning Kangyi Medical Equipment Co., Ltd
    • AccuPoint（AdvaCare Pharma）
    • Agilent
  • 熱力圖分析/企業市場分析
  • 2024年企業市佔率預測分析
Product Code: 978-1-68038-896-1

Smart Syringes Market Summary

The global smart syringes market size was estimated at USD 1.05 billion in 2024 and is projected to reach USD 2.22 billion by 2033, growing at a CAGR of 8.7% from 2025 to 2033. The growth is attributed to the increasing focus on patient and healthcare worker safety, particularly with the rise in Needle Stick Injuries (NSIs) and the transmission of blood-borne infections such as HIV and hepatitis.

Government-led vaccination drives and immunization initiatives, especially in countries such as India through the Universal Immunization Programme (UIP), have accelerated demand for auto-disable smart syringes. Moreover, regulatory bodies across the U.S. and Europe have mandated the use of safety-engineered injection devices, pushing healthcare facilities toward smart syringe adoption. Smart syringes have safety-engineered features such as retractable needles or auto-disable mechanisms, significantly reducing the risk of accidental needle-stick injuries. This has become a major public health priority, especially among healthcare workers in hospitals and clinics. For Instance, according to a report by International Journal of Surgery Global Health in 2024, Needlestick injuries (NSIs) are predominantly reported in medical and surgical departments, accounting for over 50% of all incidents.

High-risk areas include trauma and emergency rooms (38%) and operating rooms (3%). Among the key products contributing to NSIs, insulin administration in diabetic patients is a significant cause. Healthcare professionals such as emergency personnel, surgeons, and nurses are particularly at risk. Globally, the prevalence of NSIs is estimated at 42.8% among nurses, 46.4% among doctors, and 45.3% among nursing students. In general, NSI rates among nurses are approximately 41%, while nursing student rates vary widely from 8.7% to 71%.

Global initiatives aimed at expanding immunization coverage, particularly in developing regions, are significantly boosting the demand for auto-disable smart syringes. These syringes are designed for single use, effectively preventing reuse and enhancing vaccine safety. In India, the Universal Immunization Programme (UIP) is one of the largest public health efforts, reaching approximately 26.7 million newborns and 29 million pregnant women annually. Recognized as one of the most cost-effective health interventions, the UIP has significantly reduced under-five mortality rates caused by vaccine-preventable diseases.

The rising incidence of blood-borne infections such as HIV, hepatitis B (HBV), and hepatitis C (HCV) is a major driver for the smart syringe market. Unsafe injection practices, including the reuse of syringes and needles, are significant contributors to the spread of these infections, especially in developing and resource-limited healthcare settings. Smart syringes, including auto-disable and safety-engineered models, are designed to prevent reuse and accidental needlestick injuries, thereby playing a critical role in reducing transmission risks.

Global Smart Syringes Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global smart syringes market report based on product, application, distribution channel, technology, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Auto-Disable Syringes
  • Active Safety Syringes
  • Passive Safety Syringes
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Delivery
    • Insulin
    • Vaccines
    • Hormonal Therapies
    • Oncology Drugs
    • Others
  • Blood Specimen Collection
  • Catheter Syringe Flushing
  • Other Specialized Injection
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Direct Tenders (Government & NGOs)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Needle Retractable Technology
  • Needle Shielding Technology
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased Database.
  • 1.5. GVR's Internal Database
  • 1.6. Secondary Sources
  • 1.7. Third Party Perspective
  • 1.8. Primary Research
  • 1.9. Details of Primary Research
  • 1.10. Information or Data Analysis
  • 1.11. Data Analysis Models
  • 1.12. Market Formulation & Validation
  • 1.13. Model Details
  • 1.14. Commodity Flow Analysis (Model 1)
    • 1.14.1. Approach 1: Commodity Flow Approach
  • 1.15. Volume Price Analysis (Model 2)
    • 1.15.1. Approach 2: Volume Price Analysis
  • 1.16. List of Secondary Sources
  • 1.17. List of Primary Sources
  • 1.18. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Smart Syringes Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence of Needlestick Injuries (Nsis)
      • 3.2.1.2. Government Immunization Programs
      • 3.2.1.3. Technological Innovations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Smart Syringes
      • 3.2.2.2. Lack of Awareness in Developing Countries
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Increased Focus On Safe Injection Practices
      • 3.2.3.2. Rising Demand in Homecare Settings
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Limited Reusability
  • 3.3. Smart Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power of Suppliers
      • 3.3.1.2. Bargaining Power of Buyers
      • 3.3.1.3. Threat of Substitutes
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. Smart Syringes Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Smart Syringes Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Auto-Disable Syringes
    • 4.3.1. Auto-Disable Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Passive Safety Syringes
    • 4.4.1. Passive Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Active Safety Syringes
    • 4.5.1. Active Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Smart Syringes Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Smart Syringes Market: Application Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Drug Delivery
    • 5.3.1. Drug Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Insulin
      • 5.3.2.1. Insulin Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.3. Vaccines
      • 5.3.3.1. Vaccines Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.4. Hormonal Therapies
      • 5.3.4.1. Hormonal Therapies Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.5. Oncology Drugs
      • 5.3.5.1. Oncology Drugs Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.6. Others
      • 5.3.6.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.4. Blood Specimen Collection
    • 5.4.1. Blood Specimen Collection Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.5. Catheter Syringe Flushing
    • 5.5.1. Catheter Syringe Flushing Market Estimates and Forecasts 2021 to 2033 (USD Million)
  • 5.6. Other Specialized Injection
    • 5.6.1. Other Specialized Injection Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. Smart Syringes Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Smart Syringes Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Direct Tenders (Government & NGOs)
    • 6.3.1. Direct Tenders (Government & NGOs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Smart Syringes Market: Technology Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Smart Syringes Market: Technology Movement Analysis & Market Share, 2024 & 2033
  • 7.3. Needle Retractable Technology
    • 7.3.1. Needle Retractable Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Needle Shielding Technology
    • 7.4.1. Needle Shielding Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Smart Syringes Market: Regional Estimates & Trend Analysis by Product, Application, Distribution Channel, Technology

  • 8.1. Regional Outlook
  • 8.2. Smart Syringes Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. U.S. Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Canada Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Scenario
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Mexico Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. UK Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Germany Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. France Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Italy Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Spain Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Denmark Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Sweden Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Reimbursement Scenario
      • 8.4.9.5. Norway Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Japan Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. China Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. India Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. South Korea Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Australia Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Reimbursement Scenario
      • 8.5.7.5. Thailand Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Brazil Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Argentina Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. South Africa Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Saudi Arabia Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. UAE Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Reimbursement Scenario
      • 8.7.5.5. Kuwait Smart Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Becton, Dickinson and Company (BD)
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Hindustan Syringes & Medical Devices (HMD)
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Terumo Corporation
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Nipro Corporation
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Retractable Technologies, Inc.
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. SCHOTT Pharma
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Schreiner MediPharm
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Gerresheimer AG
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. SPM Medicare
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Product Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Restek Corporation
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Product Benchmarking
      • 9.2.10.4. Strategic Initiatives
    • 9.2.11. Shimadzu
      • 9.2.11.1. Company Overview
      • 9.2.11.2. Financial Performance
      • 9.2.11.3. Product Benchmarking
      • 9.2.11.4. Strategic Initiatives
    • 9.2.12. Trajan LPP
      • 9.2.12.1. Company Overview
      • 9.2.12.2. Financial Performance
      • 9.2.12.3. Product Benchmarking
      • 9.2.12.4. Strategic Initiatives
    • 9.2.13. Liaoning Kangyi Medical Equipment Co., Ltd
      • 9.2.13.1. Company Overview
      • 9.2.13.2. Financial Performance
      • 9.2.13.3. Product Benchmarking
      • 9.2.13.4. Strategic Initiatives
    • 9.2.14. AccuPoint (AdvaCare Pharma)
      • 9.2.14.1. Company Overview
      • 9.2.14.2. Financial Performance
      • 9.2.14.3. Product Benchmarking
      • 9.2.14.4. Strategic Initiatives
    • 9.2.15. Agilent
      • 9.2.15.1. Company Overview
      • 9.2.15.2. Financial Performance
      • 9.2.15.3. Product Benchmarking
      • 9.2.15.4. Strategic Initiatives
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Estimated Company Market Share Analysis, 2024

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7 North America smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 8 U.S smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 9 U.S smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11 U.S smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 12 Canada smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 13 Canada smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15 Canada smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 16 Mexico smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 19 Mexico smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 20 Europe smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24 Europe smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 26 UK smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 27 UK smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28 UK smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 29 Germany smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 30 Germany smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 31 Germany smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Germany smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 33 France smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 34 France smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 35 France smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 36 France smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Italy smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 38 Italy smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 39 Italy smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 40 Italy smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 41 Spain smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 42 Spain smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 43 Spain smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 44 Spain smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 45 Denmark smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 46 Denmark smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 47 Denmark smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 48 Denmark smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 49 Sweden smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 50 Sweden smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 51 Sweden smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52 Sweden smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 53 Norway smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 54 Norway smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 55 Norway smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56 Norway smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 62 China smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 63 China smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 64 China smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 65 China smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 66 Japan smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 67 Japan smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 68 Japan smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 69 Japan smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 70 India smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 71 India smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 72 India smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 73 India smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 74 South Korea smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 75 South Korea smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 76 South Korea smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 77 South Korea smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 78 Australia smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 79 Australia smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 80 Australia smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 81 Australia smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 82 Thailand smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 83 Thailand smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 84 Thailand smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85 Thailand smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 86 Latin America smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 87 Latin America smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 88 Latin America smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 89 Latin America smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 90 Latin America smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 91 Brazil smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 92 Brazil smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 93 Brazil smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 94 Brazil smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 95 Mexico smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 96 Mexico smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 97 Mexico smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 98 Mexico smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 99 Argentina smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 100 Argentina smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 101 Argentina smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 102 Argentina smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa smart syringes market, by country, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 108 South Africa smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 109 South Africa smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 110 South Africa smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 111 South Africa smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 116 UAE smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 117 UAE smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 118 UAE smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 119 UAE smart syringes market, by technology, 2021 - 2033 (USD Million)
  • Table 120 Kuwait smart syringes market, by product, 2021 - 2033 (USD Million)
  • Table 121 Kuwait smart syringes market, by application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait smart syringes market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 123 Kuwait smart syringes market, by technology, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Smart syringes market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Smart syringes market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping, by distribution channel
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Auto-disable syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Passive safety syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Active safety syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Drug delivery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Insulin market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Vaccines market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Hormonal therapies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Oncology drugs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Blood specimen collection market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Catheter syringe flushing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Other specialized injection market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Direct tenders (government & NGOs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Hospital pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Retail pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Online pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Needle retractable technology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Needle shielding technology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Smart syringes market: Regional key takeaways (USD Million)
  • Fig. 32 Smart syringes market: Regional outlook, 2021 & 2033 (USD Million)
  • Fig. 33 North America smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Canada smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Mexico smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Europe smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 UK smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Germany smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 France smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Spain smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Italy smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Sweden smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Norway smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Asia Pacific smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 China smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Japan smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 India smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 South Korea smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Australia smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Thailand smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Latin America smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Brazil smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Argentina smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Middle East and Africa smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 South Africa smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Saudi Arabia smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 UAE smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Kuwait smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Company market share analysis, 2024
  • Fig. 62 Market differentiators
  • Fig. 63 Competitive dashboard analysis
  • Fig. 64 Regional network map